Unknown

Dataset Information

0

Pediatric haematopoiesis and related malignancies.


ABSTRACT: Survival after acute paediatric (0-14 years), adolescent (15-19 years) and young adult (20-39 years) leukaemia has improved substantially over the last five decades, particularly for acute lymphoblastic leukaemia (ALL) and acute promyelocytic leukaemia. This progress represents one of the most successful achievements in the history of medicine and has been attributed to the development of effective chemotherapy regimens, improvement in supportive care, better risk stratification, use of targeted therapies, and advances in haematopoietic stem cell transplantation. Recent studies have revealed improvement in survival over time for all age groups and subtypes of leukaemia. However, these outcomes varied widely by age and are associated with sociodemographic and clinical factors. The present review concludes that survival and early death after acute leukaemia has greatly improved among young patients. However, inequalities in outcomes remain and are likely a result of multiple factors.

PROVIDER: S-EPMC5494839 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5538034 | BioStudies
2015-01-01 | S-EPMC4864448 | BioStudies
2009-01-01 | S-EPMC2788264 | BioStudies
1998-01-01 | S-EPMC1219833 | BioStudies
2006-01-01 | S-EPMC1654200 | BioStudies
2014-01-01 | S-EPMC4150280 | BioStudies
| S-EPMC4137593 | BioStudies
1000-01-01 | S-EPMC5605498 | BioStudies
2017-01-01 | S-EPMC5352516 | BioStudies
1000-01-01 | S-EPMC6237603 | BioStudies